IQVIA Holdings, Inc. (IQV)
264.97
-6.14
(-2.26%)
USD |
NYSE |
Nov 13, 16:00
264.97
0.00 (0.00%)
After-Hours: 19:59
IQVIA Holdings Enterprise Value : 58.70B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 58.70B |
| November 11, 2026 | 59.27B |
| November 10, 2026 | 59.37B |
| November 09, 2026 | 59.98B |
| November 06, 2026 | 58.82B |
| November 05, 2026 | 57.68B |
| November 04, 2026 | 57.50B |
| November 03, 2026 | 57.30B |
| November 02, 2026 | 56.61B |
| October 30, 2026 | 58.08B |
| October 29, 2026 | 59.35B |
| October 28, 2026 | 60.01B |
| October 27, 2026 | 58.77B |
| October 26, 2026 | 59.11B |
| October 23, 2026 | 60.06B |
| October 22, 2026 | 59.89B |
| October 21, 2026 | 59.61B |
| October 20, 2026 | 58.16B |
| October 19, 2026 | 57.84B |
| October 16, 2026 | 58.01B |
| October 15, 2026 | 58.69B |
| October 14, 2026 | 57.20B |
| October 13, 2026 | 56.98B |
| October 12, 2026 | 57.24B |
| October 09, 2026 | 56.85B |
| Date | Value |
|---|---|
| October 08, 2026 | 56.69B |
| October 07, 2026 | 56.56B |
| October 06, 2026 | 56.87B |
| October 05, 2026 | 57.87B |
| October 02, 2026 | 56.58B |
| October 01, 2026 | 56.99B |
| September 30, 2026 | 58.33B |
| September 29, 2026 | 58.57B |
| September 28, 2026 | 58.89B |
| September 25, 2026 | 58.79B |
| September 24, 2026 | 59.56B |
| September 23, 2026 | 58.38B |
| September 22, 2026 | 58.75B |
| September 21, 2026 | 58.71B |
| September 18, 2026 | 58.14B |
| September 17, 2026 | 58.64B |
| September 16, 2026 | 58.54B |
| September 15, 2026 | 58.68B |
| September 14, 2026 | 58.02B |
| September 11, 2026 | 57.38B |
| September 10, 2026 | 56.64B |
| September 09, 2026 | 56.59B |
| September 08, 2026 | 56.96B |
| September 04, 2026 | 58.37B |
| September 03, 2026 | 59.00B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Medpace Holdings, Inc. | 17.79B |
| OmniAb, Inc. | 675.91M |
| Charles River Laboratories International, Inc. | 18.99B |
| Fortrea Holdings, Inc. | 2.834B |
| Champions Oncology, Inc. | 71.90M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 352.00M |
| Revenue (Quarterly) | 4.427B |
| Total Expenses (Quarterly) | 4.077B |
| EPS Diluted (Quarterly) | 2.096 |
| Gross Profit Margin (Quarterly) | 26.56% |
| Profit Margin (Quarterly) | 7.95% |
| Earnings Yield | 3.11% |
| Operating Earnings Yield | 5.35% |
| Normalized Earnings Yield | 3.326 |